The melanocyte-stimulating hormone (MSH) 
INTRODUCTION
It is well established that in amphibians the central nervous system exerts an inhibitory control on the release of melanocyte-stimulating hormone (MSH) . Inter¬ ruption of the connexions between the hypothalamus and the pituitary by trans¬ plantation of the gland (Etkin, 1941 (Etkin, , 1943 , section of the pituitary stalk (Etkin, 1962) or lesion of the hypothalamus (Stoppani, 1941; Voitkevich, 1962 ; Kastin & Ross, 1965) results in a darkening of the skin because of the increased release of MSH. The concept that this inhibitory control is exerted through a neurosecretory sub¬ stance has received new support by the demonstration in toad hypothalamic extracts of an agent which inhibits the release of MSH (Taleisnik & Tomatis, 1967 a) .
Reserpine has been shown to be a valuable tool in studying the hypothalamohypophysial relationship of several pituitary hormones. This drug exerts a depressing action on the hypothalamus and has been shown to cause darkening of the skin in frogs and toads (Khazan & Sulman, 1961; Enemar & Falck, 1965; Iturriza, 1966) . In the present paper the effect of reserpine on the MSH content of the pituitary and and on the activity of the hypothalamic neurosecretory principles which control the release of MSH in rats and toads has been studied.
MATERIALS AND METHODS
Male albino rats (180-250 g.) (Taleisnik & Orias, 1965 (Bliss, 1952) . The results of duplicate assays were combined by the procedure of Sheps & Moore (1960) .
Crude acidic extracts were prepared with 0-1 N-HC1 from stalk-median eminence (SME) or posterior lobe tissue of rats killed with ether as previously described (Taleisnik & Orias, 1965 Effect of reserpine on MSH-BF content in rat stalk-median eminence or posterior lobe extracts The results obtained with rat SME extracts from normal or reserpine-injected animals are shown in Table 1 . As shown repeatedly extracts of SME from normal rats induced a significant depletion in pituitary MSH concentration. In contrast, SME extracts from rats injected with 0-2 mg./kg. reserpine daily for 7 days did not modify the pituitary MSH content. The duplicate assays of three extracts from three different groups of animals gave reproducible values. The mean pituitary MSH potency of the three assays was 100-3 ± 8-4 (s.E.) % while that of the controls was 62-9 + 4-9 %. The difference between both groups was highly significant (P < 0-01).
The MSH-RF content of extracts of posterior lobes taken from reserpine-injected animals was also studied. Mean of group Individual assays Effect of reserpine on MSH-R-IF activity in stalk-median eminence extracts Since the SME extracts of reserpine-injected animals did not depress the pituitary MSH content of the recipient animals as occurred with the extracts from control animals, the possibility was studied that the SME extract from reserpinized animals contained an MSH-R-IF. Consequently the ability of such extracts to inhibit the drop of pituitary MSH induced by SME extracts from normal male rats was determined. Table 2 shows that when SME extracts of reserpine-injected animals were added to SME extracts from normal rats the decrease in pituitary MSH was blocked. While the difference between the single extract and the effect seen after simultaneous treat¬ ment with an extract of animals injected with 0-2 mg./kg. reserpine for 7 days was highly significant (P < 0-01), the blocking effect of extracts from animals injected for 2 days did not attain significance (P > 0-05).
The MSH-R-IF activity in the SME of rats injected with 0-2 mg./kg. reserpine Log dose of SME 02 0-4 0-8 Fig. 2 . In A the melanocyte-stimulating hormone-release-inhibiting factor (MSH-R-IF) potency of stalk-median eminence (SME) extracts from male rats treated for 2 and 7 days with reserpine is compared. In B the MSH-R-IF potency of an extract of the SME from spayed females is compared with that of spayed females injected with reserpine. Each point is the mean melanocyte index of an aliquot from two pooled pituitaries from rats injected with a dose of SME extract of normal males to which two different doses of the SME from groups A and B were added. The vertical lines are the standard errors of the mean, n is the number of pieces of toad skin used for each point.
daily for 2 and 7 days was compared in one experiment. Extracts from treated rats were added at two dose levels (equivalent to 0-2 and 0-6 SME) to an extract of SME from normal animals and the combined extracts injected into pairs of recipient animals. The pooled pituitaries of each group were assayed for MSH activity at one dose level and the mean melanocyte index was determined in 12 pieces of skin at each point. The mean response is shown in Fig. 2 . The activity in the SME of animals injected for 7 days was 148 % ofthat of animals injected for 2 days but the difference was not significant.
Since detectable levels of MSH-R-IF are present in SME extracts from ovariectomized female rats, it was interesting to know whether these levels could be increased by reserpine. Therefore the activity of extracts of animals injected with 0-2 mg./kg. reserpine for 2 days was compared with that of non-treated animals. Figure 2 shows that in one experiment, in which equivalents of 0-2 and 0-8 of SME were added to a dose of SME from normal males, 3-09 times more inhibitory activity was found in the reserpine-injected group. This increase in activity was statistically significant (P < 0-01).
DISCUSSION
Reserpine has been shown to cause darkening of the skin when injected into frogs or toads, a result confirmed in the present study. Since this effect of reserpine is lacking in hypophysectomized animals (Iturriza, 1966) (Taleisnik, de Olmos, Orias & Tomatis, 1967) . This suggests that the MSH content on the hypophysis is to some degree regulated autonomously.
Since reserpine appears to depress the hypothalamus (Gaunt, Chart & Renzi, 1963) , the increased release of MSH after reserpine administration implies that the secre¬ tion of MSH is held in check by the central nervous system. This effect of reserpine is similar to that observed after disconnexion of the pituitary by section of the stalk, transplantation of the gland or lesions of the hypothalamus. Tranquillizing drugs also cause the release of MSH, as shown by skin darkening in frogs (Scott, 1959; Scott & Nading, 1961) and by the decrease in the MSH content of the rat pituitary (Kastin & Schally, 1966 ).
An inhibitory factor for the release of MSH has been demonstrated in hypothalamic extracts of toads (Taleisnik & Tomatis, 1967 a) and rats (Taleisnik & Tomatis, 19676) and may be the agent that physiologically restrains the release of MSH. (Shore, 1962) , it might be assumed that monoamines mediate the nervous influence which maintains a tonic secretion of MSH-R-IF under normal conditions. It should be noted that the hypothalamus also chronically inhibits the release of prolactin. The injection of reserpine induces pseudopregnancy in rats (Barraclough & Sawyer, 1959) and a lactogenic effect has been reported in rabbits (Meites, 1957) and rats (Benson, 1958) . Furthermore, after reserpine treatment a drop in pituitary prolactin content in rats (Moon & Turner, 1959) and in ovariectomized, oestrogenprimed rabbits (Kanematsu, Hilliard & Sawyer, 1963) has been described. These facts indicate that a similar mechanism may be involved in the control of secretion of MSH and prolactin. However Ratner, Talwalker & Meites (1965) found that reserpine depleted the rat hypothalamus of PIF when administered in vivo, whereas the results of the present study show that, by contrast, reserpine injection caused an increase of MSH-R-IF content in the hypothalamus by blocking its release. This work was supported by Grant NB 04732-04 from the U.S. Public Health Service.
